CoQ10 and vitamin E to reduce radiation side effects
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether taking CoQ10 and vitamin E supplements during radiation therapy can help reduce side effects for people with prostate, uterine, or anal cancer. It aims to find a safe and tolerable way to protect healthy tissue from radiation damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate, uterine (endometrial or cervical), or anal cancer confirmed by biopsy.
- You are scheduled for at least 15 sessions of radiation to the pelvic area, with or without chemotherapy, and have not had radiation to the same area before.
- You are 19 years or older and able to swallow soft-gel capsules.
- You can stop taking any vitamin E or CoQ10 supplements, and limit alcohol to 2 drinks or less around the time you take the study vitamins.
- You are willing to use effective contraception if you or your partner could become pregnant.
- You do not have bleeding disorders, are not on blood thinners that cannot be paused, and do not have other serious uncontrolled health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
This study follows people with prostate cancer who receive radiation to understand what side effects and quality-of-life changes happen over time. It may help improve standard follow-up care by better tracking radiation-related toxicity.
This study tests whether a structured exercise program can help you manage side effects from hormone therapy and radiation for prostate cancer. It aims to improve your overall well-being.
This study tests whether a combination of short-term hormone therapy (relugolix) and focused radiation (SBRT) can treat a certain type of prostate cancer that is considered favorable but has a higher genetic risk. It aims to find a less intense treatment that still works well.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial studies ways to help preserve erectile function while you receive radiation treatment for prostate cancer. It may help by aiming to protect erections, especially for people at low to intermediate risk.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.